Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

BACKGROUND: Dual antiplatelet therapy using acetylsalicylic acid (ASA, aspirin) and clopidogrel is of great importance following coronary stenting. However, the variable platelet inhibitory effectiveness compromises the antithrombotic advantages provided by dual antiplatelet therapy. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Neubauer, Horst, Kaiser, Andreas FC, Endres, Heinz G, Krüger, Jan C, Engelhardt, Andreas, Lask, Sebastian, Pepinghege, Fenena, Kusber, Andreas, Mügge, Andreas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033359/
https://www.ncbi.nlm.nih.gov/pubmed/21226927
http://dx.doi.org/10.1186/1741-7015-9-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033359/
https://www.ncbi.nlm.nih.gov/pubmed/21226927
http://dx.doi.org/10.1186/1741-7015-9-3

Ejemplares similares